PAULA ARDILA: Open Payments
NPI 1902430259 · CELEBRATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 23 payments from 11 companies in 2025. Trend: 2023 $330 · 2024 $558 · 2025 $570
Food & beverage: $470Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $173 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $125 |
| SHIELD THERAPEUTICS INC | 3 | $53 |
| Exeltis, USA Inc. | 2 | $48 |
| Biogen, Inc. | 2 | $43 |
| Organon LLC | 1 | $26 |
| MILLICENT US INC | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| Novo Nordisk Inc | 1 | $21 |
| CooperSurgical, Inc. | 1 | $20 |
Products named: Veozah, ACCRUFER, SLYND, ZURZUVAE, NEXPLANON, FEMLYV, ZEPBOUND, Paragard T 380A.
Industry payments across FL — which companies pay providers there.
